Latest News | Piramal Pharma Q1 Net Loss at Rs 82 Cr

New Delhi, Jul 29 (PTI) Piramal Pharma has reported a consolidated net loss of Rs 82 crore for the first quarter ended June 30, 2025.

The Mumbai-based drug firm had reported a loss of Rs 89 crore in the April-June quarter a year ago.

Also Read | Kolkata Fatafat Result Today, July 29, 2025: Kolkata FF Live Winning Numbers Released, Know When and Where To Check Result Chart of Satta Matka-Type Lottery Game.

Revenue from operations declined to Rs 1,934 crore in the first quarter of this fiscal, as against Rs 1,951 crore in the year-ago period, Piramal Pharma said in a late night regulatory filing on Monday.

"Excluding the impact of destocking in one large on-patent commercial product, our CDMO business delivered mid-teen revenue growth during the quarter accompanied by improvement in EBITDA margin, especially at our overseas sites," Piramal Pharma Ltd Chairperson Nandini Piramal said.

Also Read | Shillong Teer Results Today, July 29 2025: Winning Numbers, Result Chart for Shillong Morning Teer, Shillong Night Teer, Khanapara Teer, Juwai Teer and Jowai Ladrymbai.

Growth in complex hospital generics (CHG) business is also expected to pick up for the remaining part of the year given the timing of some of the institutional orders, she added.

"Withstanding the near-term challenges, we believe we are on track to achieve our FY2030 aspirations of becoming a USD 2 billion revenue company with 25 per cent EBITDA margin and high-teen ROCE," Piramal said.

Shares of the company were trading 1.05 per cent down at Rs 202.20 apiece on BSE.

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)